Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC3 | O15379 | 2/20 | 0.39 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.39 |
| ▸ | VDR | P11473 | 13/20 | 0.36 |
| ▸ | TAS1R3 | Q7RTX0 | 2/20 | 0.32 |
| ▸ | TAS1R1 | Q7RTX1 | 2/20 | 0.32 |
| ▸ | F2 | P00734 | 1/20 | 0.31 |
| ▸ | F10 | P00742 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6278407 | 0.93 | HDAC6 (0.39) | HDAC3HDAC6VDRTAS1R3TAS1R1 | |
| SCHEMBL6265176 | 0.89 | HDAC3 (0.42) | HDAC3HDAC6VDRTAS1R3TAS1R1 | |
| SCHEMBL6259404 | 0.87 | HDAC3 (0.41) | HDAC3HDAC6VDR | |
| SCHEMBL6259000 | 0.83 | HDAC3 (0.39) | HDAC3HDAC6VDRTAS1R3TAS1R1 | |
| SCHEMBL3392543 | 0.80 | HDAC3 (0.39) | HDAC3HDAC6VDR | |
| SCHEMBL6261217 | 0.79 | VDR (0.49) | HDAC3HDAC6VDR | |
| SCHEMBL6262125 | 0.79 | HDAC3 (0.32) | HDAC3HDAC6F2F10 | |
| SCHEMBL5971817 | 0.77 | HDAC3 (0.38) | HDAC3HDAC6VDRTAS1R3TAS1R1 | |
| SCHEMBL3392542 | 0.77 | HDAC3 (0.53) | HDAC3HDAC6VDR | |
| SCHEMBL5971357 | 0.77 | VDR (0.38) | HDAC3HDAC6VDRTAS1R3TAS1R1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1587905-A3 | VESICANT TREATMENT WITH PHENYL-THIOPHENE TYPE VITAMIN D RECEPTOR MODULATORS | ELI LILLY AND COMPANY (US) | 2005-12-14 | — | — | EP | disclosed |
| EP-1587905-A2 | VESICANT TREATMENT WITH PHENYL-THIOPHENE TYPE VITAMIN D RECEPTOR MODULATORS | ELI LILLY AND COMPANY (US) | 2005-10-26 | — | — | EP | disclosed |
| WO-2004063348-A2 | VESICANT TREATMENT WITH PHENYL-THIOPHENE TYPE VITAMIN D RECEPTOR MODULATORS | ELI LILLY AND COMPANY (US) | 2004-07-29 | — | — | WO | disclosed |